Supply Chain

The U.K.'s National Institute for Health and Care Excellence will join the Food and Drug Administration's Payer Communication Task Force to help more medical devices, diagnostics and other health-related technologies reach the market faster, reports RAPS.

Mondher Mahjoubi will leave his role as head of AstraZeneca's oncology division to serve as the new CEO of Innate Pharma, a French biotech focusing on immuno-oncology therapies, reports Reuters.

Amazon may be developing — or looking to acquire — a mobile technology to link available trucks with shipments needing to be transported, reports The Wall Street Journal.

As drug prices continue to rise, many U.S. hospitals are implementing aggressive strategies to reduce pharmaceutical spending, reports The Wall Street Journal.

The Food and Drug Administration will allow Pfizer to remove a serious warning from the label of its anti-smoking drug Chantix, reports Fox News.

Actavis could face fines for raising the price of its steroid treatment by more than 12,000 percent, reports Bloomberg.

Companies must untangle a complex web of factors when deciding not only where to locate a distribution center, but also how to run it, reports DC Velocity.

Tompkins International, a large-scale supply chain consulting firm, will take on a new role as a fourth-party logistics provider, reports DC Velocity.

Twenty U.S. states filed a lawsuit Thursday against six generic drugmakers, alleging they colluded to set fixed prices of two common drugs and split up market share, reports Reuters.

Kenilworth, N.J.-based Merck & Co. received $2.54 billion in royalties on Thursday through a patent lawsuit against Gilead Sciences' best-selling hepatitis C drugs Sovaldi and Harvoni, reports Reuters.